메뉴 건너뛰기




Volumn 38, Issue 3, 2003, Pages 639-644

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

EID: 0043037223     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50350     Document Type: Article
Times cited : (336)

References (29)
  • 1
    • 1842291578 scopus 로고    scopus 로고
    • The treatment of chronic viral hepatitis
    • Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
    • (1997) N Engl J Med , vol.336 , pp. 347-356
    • Hoofnagle, J.H.1    Di Bisceglie, A.M.2
  • 2
    • 0031821318 scopus 로고    scopus 로고
    • Human leukocyte antigen class II alleles may affect response of chronic hepatitis C to Interferon therapy
    • Sim KH, Wojcik JP, Margulies M, Wade J, Heathcote J. Human leukocyte antigen class II alleles may affect response of chronic hepatitis C to Interferon therapy. J Viral Hepat 1998;5:249-253.
    • (1998) J Viral Hepat , vol.5 , pp. 249-253
    • Sim, K.H.1    Wojcik, J.P.2    Margulies, M.3    Wade, J.4    Heathcote, J.5
  • 4
    • 0025671752 scopus 로고
    • Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group
    • Gomez-Rubio M, Porres JC, Castillo I, Quiroga JA, Moreno A, Carreno V. Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group. J Hepatol 1990;11:S63-S67.
    • (1990) J Hepatol , vol.11
    • Gomez-Rubio, M.1    Porres, J.C.2    Castillo, I.3    Quiroga, J.A.4    Moreno, A.5    Carreno, V.6
  • 5
    • 0027416870 scopus 로고
    • Treatment of chronic hepatitis C with high-dose interferon alpha 2b. A multicenter study
    • Iino S, Hino K, Kuroki T, Suzuki H, Yamamoto S. Treatment of chronic hepatitis C with high-dose interferon alpha 2b. A multicenter study. Dig Dis Sci 1993;38:612-618.
    • (1993) Dig Dis Sci , vol.38 , pp. 612-618
    • Iino, S.1    Hino, K.2    Kuroki, T.3    Suzuki, H.4    Yamamoto, S.5
  • 6
    • 0030885469 scopus 로고    scopus 로고
    • Factors predictive of a beneficial response to therapy of hepatitis C
    • Davis GL, Lau JY. Factors predictive of a beneficial response to therapy of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):122S.
    • (1997) Hepatology , vol.26 , Issue.SUPPL. 1
    • Davis, G.L.1    Lau, J.Y.2
  • 7
    • 0029084933 scopus 로고
    • Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
    • Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. HEPATOLOGY 1995;22:1050-1056.
    • (1995) Hepatology , vol.22 , pp. 1050-1056
    • Martinot-Peignoux, M.1    Marcellin, P.2    Pouteau, M.3    Castelnau, C.4    Boyer, N.5    Poliquin, M.6    Degott, C.7
  • 8
    • 0032841858 scopus 로고    scopus 로고
    • Racial differences in response to therapy with interferon in chronic hepatitis C
    • Reddy KR, Hoofnagle JH, Tong MJ. Racial differences in response to therapy with interferon in chronic hepatitis C. HEPATOLOGY 1999;30:78.
    • (1999) Hepatology , vol.30 , pp. 78
    • Reddy, K.R.1    Hoofnagle, J.H.2    Tong, M.J.3
  • 9
    • 0027322553 scopus 로고
    • Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C
    • Perez R, Pravia R, Linares A, Rodriguez M, Lombrana JL, Suarez A, Riestra S, et al. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C. Gut 1993;34(Suppl):S139-S140.
    • (1993) Gut , vol.34 , Issue.SUPPL.
    • Perez, R.1    Pravia, R.2    Linares, A.3    Rodriguez, M.4    Lombrana, J.L.5    Suarez, A.6    Riestra, S.7
  • 10
    • 0027385541 scopus 로고
    • Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables
    • Camps J, Crisostomo S, Garcia-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut 1993;34:1714-1717.
    • (1993) Gut , vol.34 , pp. 1714-1717
    • Camps, J.1    Crisostomo, S.2    Garcia-Granero, M.3    Riezu-Boj, J.I.4    Civeira, M.P.5    Prieto, J.6
  • 11
    • 15144359118 scopus 로고    scopus 로고
    • Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection
    • Hayashi J, Kishihara Y, Ueno K, Yamaji K, Kawakami Y, Furusyo N, Sawayama Y, et al. Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection. Arch Intern Med 1998;158:177-181.
    • (1998) Arch Intern Med , vol.158 , pp. 177-181
    • Hayashi, J.1    Kishihara, Y.2    Ueno, K.3    Yamaji, K.4    Kawakami, Y.5    Furusyo, N.6    Sawayama, Y.7
  • 14
    • 0033762069 scopus 로고    scopus 로고
    • Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C
    • Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, et al. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2000;95:3211-3217.
    • (2000) Am J Gastroenterol , vol.95 , pp. 3211-3217
    • Giannini, E.1    Ceppa, P.2    Botta, F.3    Mastracci, L.4    Romagnoli, P.5    Comino, I.6    Pasini, A.7
  • 15
    • 0034987263 scopus 로고    scopus 로고
    • Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    • Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. HEPATOLOGY 2001;33:1358-1364.
    • (2001) Hepatology , vol.33 , pp. 1358-1364
    • Adinolfi, L.E.1    Gambardella, M.2    Andreana, A.3    Tripodi, M.F.4    Utili, R.5    Ruggiero, G.6
  • 16
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • International Hepatitis Interventional Therapy Group (IHIT)
    • Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352:1426-1432.
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3    Niederau, C.4    Minuk, G.S.5    Ideo, G.6    Bain, V.7
  • 18
    • 0028566409 scopus 로고
    • Clinical and histologic predictors of response to interferon-α in patients with chronic hepatitis C viral infection
    • Lam NP, DeGuzman LJ, Pitrak D, Layden TJ. Clinical and histologic predictors of response to interferon-α in patients with chronic hepatitis C viral infection. Dig Dis Sci 1994;39:2660-2664.
    • (1994) Dig Dis Sci , vol.39 , pp. 2660-2664
    • Lam, N.P.1    DeGuzman, L.J.2    Pitrak, D.3    Layden, T.J.4
  • 19
    • 0031025974 scopus 로고    scopus 로고
    • Effect of obesity on pharmacokinetics and biologic effect of interferon-α in hepatitis C
    • Lam NP, Pitrak D, Speralakis R, Lau AH, Wiley TE, Layden TJ. Effect of obesity on pharmacokinetics and biologic effect ofinterferon-α in hepatitis C. Dig Dis Sci 1997;42:178-185.
    • (1997) Dig Dis Sci , vol.42 , pp. 178-185
    • Lam, N.P.1    Pitrak, D.2    Speralakis, R.3    Lau, A.H.4    Wiley, T.E.5    Layden, T.J.6
  • 22
    • 4244195920 scopus 로고    scopus 로고
    • The Laennec grading system for assessment of hepatic fibrosis: Validation by correlation with edged hepatic vein pressure and clinical features
    • Kutami R, Girgrah N, Wanless IR, Sniderman K, Wong FS, Sherman M, Heathcote J, et al. The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with edged hepatic vein pressure and clinical features [Abstract]. HEPATOLOGY 2000;32:407a.
    • (2000) Hepatology , vol.32
    • Kutami, R.1    Girgrah, N.2    Wanless, I.R.3    Sniderman, K.4    Wong, F.S.5    Sherman, M.6    Heathcote, J.7
  • 23
    • 0028234491 scopus 로고
    • Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C
    • The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
    • (1994) Hepatology , vol.20 , pp. 15-20
  • 25
    • 0032873596 scopus 로고    scopus 로고
    • Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients
    • Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Cresta E, Venturino V, et al. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients. Liver 1999;19:432-437.
    • (1999) Liver , vol.19 , pp. 432-437
    • Giannini, E.1    Ceppa, P.2    Botta, F.3    Fasoli, A.4    Romagnoli, P.5    Cresta, E.6    Venturino, V.7
  • 26
    • 0034857085 scopus 로고    scopus 로고
    • Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy?
    • Giannini E, Ceppa P, Testa R. Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? J Hepatol 2001;35:432-433.
    • (2001) J Hepatol , vol.35 , pp. 432-433
    • Giannini, E.1    Ceppa, P.2    Testa, R.3
  • 27
    • 17944381054 scopus 로고    scopus 로고
    • Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon
    • Rubbia-Brandt L, Giostra E, Mentha G, Quadri R, Negro F. Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon. J Hepatol 2001;35:307.
    • (2001) J Hepatol , vol.35 , pp. 307
    • Rubbia-Brandt, L.1    Giostra, E.2    Mentha, G.3    Quadri, R.4    Negro, F.5
  • 28
    • 0034020054 scopus 로고    scopus 로고
    • Lymphatic transport of proteins after subcutaneous administration
    • Porter CJH, Charman SA. Lymphatic transport of proteins after subcutaneous administration (mini-review). J Pharm Sci 2000;89:297-310.
    • (2000) J Pharm Sci , vol.89 , pp. 297-310
    • Porter, C.J.H.1    Charman, S.A.2
  • 29
    • 0034919249 scopus 로고    scopus 로고
    • Obesity predisposes to increased drainage following axillary node clearance: A prospective audit
    • Banerjee D, Williams EV, Ilott J, Monypenny IJ, Webster DJ. Obesity predisposes to increased drainage following axillary node clearance: a prospective audit. Ann R Coll Surg Engl 2001;83:268-271.
    • (2001) Ann R Coll Surg Engl , vol.83 , pp. 268-271
    • Banerjee, D.1    Williams, E.V.2    Ilott, J.3    Monypenny, I.J.4    Webster, D.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.